FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $90,439 | -33.8% | 31,733 | +69.1% | 0.00% | – |
| Q4 2022 | $136,631 | -28.8% | 18,768 | -20.9% | 0.00% | – |
| Q3 2022 | $192,000 | +82.9% | 23,730 | +10.6% | 0.00% | – |
| Q2 2022 | $105,000 | -82.4% | 21,450 | -15.2% | 0.00% | – |
| Q1 2022 | $598,000 | +23.6% | 25,299 | -7.6% | 0.00% | – |
| Q4 2021 | $484,000 | -53.1% | 27,387 | -25.2% | 0.00% | – |
| Q3 2021 | $1,032,000 | +647.8% | 36,595 | +178.3% | 0.00% | – |
| Q2 2021 | $138,000 | +17.9% | 13,150 | +32.2% | 0.00% | – |
| Q1 2021 | $117,000 | -7.9% | 9,947 | -8.2% | 0.00% | – |
| Q4 2020 | $127,000 | +104.8% | 10,838 | +38.5% | 0.00% | – |
| Q3 2020 | $62,000 | -47.0% | 7,827 | +22.1% | 0.00% | – |
| Q2 2020 | $117,000 | +108.9% | 6,410 | +38.3% | 0.00% | – |
| Q1 2020 | $56,000 | +124.0% | 4,636 | +207.0% | 0.00% | – |
| Q4 2019 | $25,000 | +257.1% | 1,510 | +25.7% | 0.00% | – |
| Q3 2019 | $7,000 | – | 1,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |